Larissa Schwartz sells OKTA shares under 10b5-1
Larissa Schwartz reported proposed and recent sales of Common stock under a 10b5-1 plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Larissa Schwartz reported proposed and recent sales of Common stock under a 10b5-1 plan. The filing lists six 10b5-1 transactions on 02/06/2026 and 03/10/2026 with per-transaction share counts and gross proceeds: 1,054 shares for $87,977.38, 126 shares for $10,517.22, 656 shares for $54,756.32 (02/06/2026); and 1,054 shares for $84,320.00, 126 shares for $10,048.50, 656 shares for $52,316.00 (03/10/2026).
Key Figures
Key Terms
10b5-1 regulatory
RSUs financial
ESPP financial
Form 144 regulatory
Restricted Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Form 144 for OKTA disclose about Larissa Schwartz's transactions?
What were the sale details reported on 03/10/2026 in the filing for OKTA?
Does the filing show the source of the sold securities (RSUs/ESPP) for OKTA?
Were these transactions conducted under a pre-arranged trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.